Most Recent Links
Follow us on Facebook and Twitter, or subscribe to our mailing list, to receive news updates. Learn more.
By Rachael Lallensack Goats know who their real friends are. A study published today in Royal Society Open Science shows that the animals can recognize what other goats look like and sound like, but only those they are closest with. Up until the late 1960s, the overwhelming assumption was that only humans could mentally keep track of how other individuals look, smell, and sound—what scientists call cross-modal recognition. We now know that many different kinds of animals can do this like horses, lions, crows, dogs, and certain primates. Instead of a lab, these researchers settled into Buttercups Sanctuary for Goats in Boughton Monchelsea, U.K., to find out whether goats had the ability to recognize each other. To do so, they first recorded the calls of individual goats. Then, they set up three pens in the shape of a triangle in the sanctuary’s pasture. Equidistant between the two pens at the base of the triangle was a stereo speaker, camouflaged as to not distract the goat participants. A “watcher” goat stood at the peak of the triangle, and the two remaining corners were filled with the watcher’s “stablemate” (they share a stall at night) and a random herd member. Then, the team would play either the stablemate’s or the random goat’s call over the speaker and time how long it took for the watcher to match the call with the correct goat. They repeated this test again, but with two random goats. The researchers found that the watcher goat would look at the goat that matched the call quickly and for a longer time, but only in the test that included their stablemate. The results indicate that goats are not only capable of cross-modal recognition, but that they might also be able to use inferential reasoning, in other words, process of elimination. Think back to the test: Perhaps when the goat heard a call that it knew was not its pal, it inferred that it must have been the other one. © 2017 American Association for the Advancement of Science.
Jon Hamilton Researchers have created mice that appear impervious to the lure of cocaine. Even after the genetically engineered animals were given the drug repeatedly, they did not appear to crave it the way typical mice do, a team reports in Nature Neuroscience. "They didn't keep going into the room where they received the cocaine and they seemed to be just as happy exploring all around the cage," says Shernaz Bamji, a professor in the Department of Cellular and Physiological Sciences at the University of British Columbia in Vancouver. "Addiction is a form of learning," Bamji says. And somehow, these mice never learned to associate the pleasurable feelings produced by cocaine with the place where they received the drug. The result was startling because the scientists thought these mice would be especially susceptible to addiction. "We repeated the experiment several times to see if we had made a mistake," Bamji says. The reason for the team's surprise had to do with proteins that affect learning. The animals had been genetically engineered to produce high levels of proteins called cadherins in the brain's "reward circuit," which plays an important role in addiction. And genetic studies have suggested that people with high levels of cadherins are more susceptible to drug addiction. Cadherins act a bit like glue, binding cells together. Usually this glue enhances learning by strengthening the connections, or synapses, between brain cells. © 2017 npr
Ian Sample Science editor Children who are born very prematurely are at greater risk of developing mental health and social problems that can persist well into adulthood, according to one of the largest reviews of evidence. Those with an extremely low birth weight, at less than a kilogram, are more likely to have attention disorders and social difficulties as children, and feel more shyness, anxiety and depression as adults, than those born a healthy weight. The review draws on findings from 41 published studies over the past 26 years and highlights the need for doctors to follow closely how children born very prematurely fare as they become teenagers and adults. “It is important that families and doctors be aware of the potential for these early-emerging mental health problems in children born at extremely low birth weight, since at least some of them endure into adulthood,” said Karen Mathewson, a psychologist at McMaster University in Ontario. Improvements in neonatal care in the past two decades mean that more children who are born very prematurely now survive. In a healthy pregnancy, a baby can reach 1kg (a little more than 2lbs) within 27 weeks, or the end of the second trimester. The study, which involves data from 13,000 children in 12 different countries, follows previous research that found a greater tendency for very low birth weight children to have lower IQs and autism and more trouble with relationships and careers as they reach adulthood and venture into the world. © 2017 Guardian News and Media Limited
By Andy Coghlan It’s as if a switch has been flicked. Evidence is mounting that chronic fatigue syndrome (CFS) is caused by the body swapping to less efficient ways of generating energy. Also known as ME or myalgic encephalomyelitis, CFS affects some 250,000 people in the UK. The main symptom is persistent physical and mental exhaustion that doesn’t improve with sleep or rest. It often begins after a mild infection, but its causes are unknown. Some have argued that CFS is a psychological condition, and that it is best treated through strategies like cognitive behavioural therapy. But several lines of investigation are now suggesting that the profound and painful lack of energy seen in the condition could in many cases be due to people losing their ability to burn carbohydrate sugars in the normal way to generate cellular energy. Instead, the cells of people with CFS stop making as much energy from sugar as usual, and start relying more on lower-yielding fuels, such as amino acids and fats. This kind of metabolic switch produces lactate, which can cause pain when it accumulates in muscles. Together, this would explain both the shortness of energy, and why even mild exercise can be exhausting and painful. © Copyright Reed Business Information Ltd.
Link ID: 23226 - Posted: 02.14.2017
By BENEDICT CAREY The number of retirement-age Americans taking at least three psychiatric drugs more than doubled between 2004 and 2013, even though almost half of them had no mental health diagnosis on record, researchers reported on Monday. The new analysis, based on data from doctors’ office visits, suggests that inappropriate prescribing to older people is more common than previously thought. Office visits are a close, if not exact, estimate of underlying patient numbers. The paper appears in the journal JAMA Internal Medicine. Geriatric medical organizations have long warned against overprescribing to older people, who are more susceptible to common side effects of psychotropic drugs, such as dizziness and confusion. For more than 20 years, the American Geriatrics Society has published the so-called Beers Criteria for potentially inappropriate use, listing dozens of drugs and their mutual interactions. In that time, prescription rates of drugs like antidepressants, sleeping pills and painkillers nonetheless generally increased in older people, previous studies have found. The new report captures one important dimension, the rise in so-called polypharmacy — three drugs or more — in primary care, where most of the prescribing happens. Earlier research has found that elderly people are more likely to be on at least one psychiatric drug long term than younger adults, even though the incidence of most mental disorders declines later in life. “I was stunned to see this, that despite all the talk about how polypharmacy is bad for older people, this rate has doubled,” said Dr. Dilip Jeste, a professor of psychiatry and neurosciences at the University of California, San Diego, who was not involved in the new work. © 2017 The New York Times Company
By Virginia Morell Strange as it might seem, not all animals can immediately recognize themselves in a mirror. Great apes, dolphins, Asian elephants, and Eurasian magpies can do this—as can human kids around age 2. Now, some scientists are welcoming another creature to this exclusive club: carefully trained rhesus monkeys. The findings suggest that with time and teaching, other animals can learn how mirrors work, and thus learn to recognize themselves—a key test of cognition. “It’s a really interesting paper because it shows not only what the monkeys can’t do, but what it takes for them to succeed,” says Diana Reiss, a cognitive psychologist at Hunter College in New York City, who has given the test to dolphins and Asian elephants in other experiments. The mirror self-recognition test (MSR) is revered as a means of testing self-awareness. A scientist places a colored, odorless mark on an animal where it can’t see it, usually the head or shoulder. If the animal looks in the mirror and spontaneously rubs the mark, it passes the exam. Successful species are said to understand the concept of “self” versus “other.” But some researchers wonder whether failure is simply a sign that the exam itself is inadequate, perhaps because some animals can’t understand how mirrors work. Some animals—like rhesus monkeys, dogs, and pigs—don’t recognize themselves in mirrors, but can use them to find food. That discrepancy puzzled Mu-ming Poo, a neurobiologist at the Shanghai Institutes for Biological Sciences in China, and one of the study’s authors. “There must be some transition between that simple mirror use and recognizing yourself,” he says. © 2017 American Association for the Advancement of Science.
Richard A. Friedman Psychedelics, the fabled enlightenment drugs of the ’60s, are making a comeback — this time as medical treatment. A recent study claimed that psilocybin, a mushroom-derived hallucinogenic, relieves anxiety and depression in people with life-threatening cancer. Anecdotal reports have said similar things about so-called microdoses of LSD. The allure is understandable, given the limits of our treatments for depression and anxiety. About a third of patients with major depression don’t get better, even after several trials of different antidepressants. But I fear that in our desire to combat suffering, we will ignore the potential risks of these drugs, or be seduced by preliminary research that seems promising. This appears to be the case with the new psilocybin study, which has some serious design flaws that cast doubt on the results (and which the authors mention briefly). The study, done at New York University School of Medicine, examined a very small number of people with cancer in a “crossover” design in which each subject served as her own control, sequentially receiving doses of psilocybin and the control drug niacin, in random order. (Another recent study of psilocybin, done at Johns Hopkins University, used a similar crossover design.) Psilocybin, being a hallucinogen, has immediately recognizable mental effects, so subjects would almost certainly know when they were getting it compared with niacin, a vitamin that causes flushing but has no discernible effect on mood or thinking. This makes it hard to know if subjects got better because of the psilocybin, or because of a placebo effect. The design also means that subjects who got psilocybin first could have had a “carry-over effect” from the drug when they received niacin. In other words, they might still have been under the influence, contaminating the control condition. © 2017 The New York Times Company
By Sam Wong Here’s looking at you, squid. Cock-eyed squid have one huge, bulging eye and another normal-sized eye, but the reason has remained a mystery. Now we have an answer. Kate Thomas of Duke University in North Carolina studied 161 videos of the creatures collected over 26 years by remotely operated submarines in Monterey Bay, California. The findings provide the first behavioural evidence that the two eyes are adapted to look in different directions. The large one points upwards to spot prey silhouetted against the sky. The smaller one points downwards to spot bioluminescent organisms against the darkness below. The squid, from the histioteuthid family, live at depths of 200 to 1000 metres, where little light penetrates. The videos show that the squid normally swims with its tail end pointing upwards, but tilted so the large eye is consistently oriented towards the sky. Based on measurements of the eyes and the light levels they would be exposed to, Thomas and her colleagues calculated that having a big upward-pointing eye greatly improves visual perception, while a downward-pointing eye would gain little from being large. “That gives you the context for how this trait might have evolved,” says Thomas. Some of the squid’s prey, such as lanternfish and shrimp, have luminescent undersides so they are camouflaged against the sunlight when seen from below. Yellow pigmentation in the lens of the squid’s large eye may help it distinguish between sunlight and bioluminescence. © Copyright Reed Business Information Ltd.
Moises Velasquez-Manoff This Valentine’s Day, as you bask in the beauty of your beloved, don’t just thank his or her genes and your good fortune; thank microbes. Research on the microbes that inhabit our bodies has progressed rapidly in recent years. Scientists think that these communities, most of which live in the gut, shape our health in myriad ways, affecting our vulnerability to allergic diseases like hay fever, how much weight we put on, our susceptibility to infection and maybe even our moods. They can also, it seems, make us sexy. Susan Erdman, a microbiologist at M.I.T., calls it the “glow of health.” The microbes you harbor, she argues, can make your skin smooth and your hair shiny; they may even put a spring in your step. She stumbled on the possibility some years ago when, after feeding mice a probiotic microbe originally isolated from human breast milk, a technician in her lab noticed that the animals grew unusually lustrous fur. Further observation of males revealed thick skin bristling with active follicles, elevated testosterone levels and oversize testicles, which the animals liked showing off. Microbes had transformed these animals into rodent heartthrobs. When given to females, the probiotic also prompted deeper changes. Levels of a protein called interleukin 10, which helps to prevent inflammatory disease and ensure successful pregnancy, went up, as did an important hormone called oxytocin. Oxytocin, often called the love hormone, helps mammals bond with one another. Our bodies may release it when we kiss (and mean it), when women breast-feed, even when people hang out with good friends. And the elevated oxytocin Dr. Erdman saw had important effects during motherhood. Some of the mice in her studies were eating a high-fat, high-sugar diet — junk-foody fare that’s known to shift the microbiome into an unhealthy state. Not surprisingly perhaps, mothers that didn’t imbibe the probiotics were less caring and tended to neglect their pups. But mothers that had high oxytocin thanks to the probiotic were nurturing and reared their pups more successfully. © 2017 The New York Times Company
Patti Neighmond It's tough to be a teenager. Hormones kick in, peer pressures escalate and academic expectations loom large. Kids become more aware of their environment in the teen years — down the block and online. The whole mix of changes can increase stress, anxiety and the risk of depression among all teens, research has long shown. But a recent study published in the journal Pediatrics suggests many more teenage girls in the U.S. may be experiencing major depressive episodes at this age than boys. And the numbers of teens affected took a particularly big jump after 2011, the scientists note, suggesting that the increasing dependence on social media by this age group may be exacerbating the problem. Psychiatrist Ramin Mojtabai and colleagues at Johns Hopkins University Bloomberg School of Public Health wanted to know whether rates of depression among teens had increased over the past decade. They analyzed federal data from interviews with more than 172,000 adolescents. Between 2005 and 2014, the scientists found, rates of depression went up significantly — if extrapolated to all U.S. teens it would work out to about a half million more depressed teens. What's more, three-fourths of those depressed teens in the study were girls. The findings are just the latest in a steady stream of research showing that women of all ages experience higher rates of depression compared to men, says psychologist and author Catherine Steiner-Adair. And no wonder, she says — despite gains in employment, education and salary, women and girls are still "continually bombarded by media messages, dominant culture, humor and even political figures about how they look — no matter how smart, gifted, or passionate they are." © 2017 npr
By JANE E. BRODY “Bariatric surgery is probably the most effective intervention we have in health care,” says Laurie K. Twells, a clinical epidemiologist at Memorial University of Newfoundland. She bases this bold claim on her experience with seriously obese patients and a detailed analysis of the best studies yet done showing weight-loss surgery’s ability to reverse the often devastating effects of being extremely overweight on health and quality of life. “I haven’t come across a patient yet who wouldn’t recommend it,” Dr. Twells said in an interview. “Most say they wish they’d done it 10 years sooner.” She explained that the overwhelming majority of patients who undergo bariatric surgery have spent many years trying — and failing — to lose weight and keep it off. And the reason is not a lack of willpower. “These patients have lost hundreds of pounds over and over again,” Dr. Twells said. “The weight that it takes them one year to lose is typically back in two months,” often because a body with longstanding obesity defends itself against weight loss by drastically reducing its metabolic rate, an effect not seen after bariatric surgery, which permanently changes the contours of the digestive tract. In reviewing studies that followed patients for five to 25 years after weight-loss surgery, Dr. Twells and colleagues found major long-lasting benefits to the patients’ health and quality of life. Matched with comparable patients who did not have surgery, those who did fared much better physically, emotionally and socially. They rated themselves as healthier and were less likely to report problems with mobility, pain, daily activities, social interactions and feelings of depression and anxiety, among other factors that can compromise well-being. © 2017 The New York Times Company
Link ID: 23219 - Posted: 02.13.2017
By Abigail Zuger, M.D. It was in 2011 that the Centers for Disease Control first drew public attention to the ongoing nationwide opioid crisis. Much earnest commentary has explored the roots of this new killer epidemic since then, focusing on the broad highway between heroin and pain pills, and the online pharmacies, pill mills, and bad-apple doctors who fueled the two-way traffic and enabled catastrophe. Forgive me for rolling my eyes. Anyone with a prescription pad and a shred of common sense saw this whole thing coming down the pike decades ago, a speeding 18-wheeler, tires squealing, no brakes. Furthermore, it has long been clear that while the bad medical apples certainly did their share of damage, there is not a health policy guru or medical school dean in the country whose sins of omission and commission are not also partly responsible. Call it an epidemic of unconscious collusion or, as Dr. Anna Lembke bluntly states, a nation’s doctors “trapped in a system gone mad.” In less than 200 pages, this may be the most important medical book of the decade for finally getting the story of the opioid epidemic exactly right. As far as I am concerned, “Drug Dealer, M.D.,” in less than 200 unassuming, readable, and carefully referenced pages, may be the most important medical book of the decade for finally getting the story of this epidemic exactly right. And it’s not the medical bad apples Lembke is talking about in her title — it’s every doctor in the country. Copyright 2017 Undark
By KENNETH CHANG Sir Peter Mansfield, who shared a Nobel Prize for discoveries that underpinned the invention of magnetic resonance imaging, the method of peering inside the human body that revolutionized medicine, died on Wednesday. He was 83. The University of Nottingham in England, where Dr. Mansfield had been a professor of physics, announced his death but not did say where he died. He lived in England. Magnetic resonance imaging, or M.R.I., has enabled doctors to diagnose and examine injuries to ligaments, bones and organs without cutting open the body or risking the radiation dangers of X-rays. “It’s hugely important,” said Charles P. Slichter, an emeritus physics professor at the University of Illinois at Urbana-Champaign. “It’s such an all-pervasive technique.” Dr. Mansfield worked in his laboratory as a postdoctoral researcher in the 1960s. Dr. Mansfield was awarded the Nobel Prize in Physiology or Medicine in 2003, along with Paul C. Lauterbur, a professor at the University of Illinois at Urbana-Champaign. The two had worked independent of each other in studying magnetic resonance imaging. Their research proceeded from an understanding that the nuclei of most atoms act as tiny magnets that line up when placed in a magnetic field. If the field is set at a specific strength, the atoms can absorb and emit radio waves. Scientists initially used the technique, called nuclear magnetic resonance, or N.M.R., to study atoms and molecules, deducing properties from the emitted waves. In his early research, Dr. Mansfield developed N.M.R. techniques to study crystals. Later, in 1972, as he worked to refine and sharpen N.M.R. data, he had a conversation with two colleagues about what applications such advances might lead to. He soon realized that if an object were placed in a nonuniform magnetic field — one that is stronger at one end than the other — scientists might be able to piece together a three-dimensional image of its atomic structure. © 2017 The New York Times Company
Keyword: Brain imaging
Link ID: 23217 - Posted: 02.13.2017
By Matt Blois A ruthless killer may soon help brain cancer patients. The rabies virus, which kills tens of thousands of people a year, has a rare ability to enter nerve cells and use them as a conduit to infect brain tissue. Now, scientists are trying to mimic this strategy to ferry tumor-killing nanoparticles into brain tumors. So far the approach has been shown to work only in mice. If successful in people, these nanoparticles could one day help doctors send treatment directly to tumors without harming healthy cells. The rabies virus, transmitted largely through the bites of infected animals, has evolved over thousands of years to hijack nerve cells, which it uses to climb from infected muscle tissue into the brain. That allows it to bypass a major hurdle: the blood-brain barrier, a selective membrane that keeps out most pathogens that travel through the bloodstream. But the barrier also prevents treatments—like cancer drugs—from reaching infected cells, limiting options for patients. To get around this problem, scientists are looking to the virus for inspiration. Already, researchers have packaged cancer-fighting drugs into nanoparticles coated with part of a rabies surface protein that lets the virus slip into the central nervous system. Now, a team of researchers from Sungkyunkwan University in Suwon, South Korea, has taken things one step further. Nanoparticle expert Yu Seok Youn and his team have engineered gold particles so that they have the same rodlike shape and size as the virus. The nanoparticle’s shape gives it more surface area than spherical particles, improving the surface protein’s ability to bind with receptors on nerve cells that serve as a gateway to the nervous system. The particles don’t carry any drugs, but the tiny gold rods readily absorb laser light, which heats them up and kills surrounding tissue. © 2017 American Association for the Advancement of Science.
By KATHARINE Q. SEELYE and ABBY GOODNOUGH MANCHESTER, N.H. — Chad Diaz began using heroin when he was 12. Now 36 and newly covered by Medicaid under the Affordable Care Act, he is on Suboxone, a substitute opioid that eases withdrawal symptoms and cravings, and he is slowly pulling himself together. “This is the best my life has gone in many, many years,” Mr. Diaz, a big man wearing camouflage, said as he sat in a community health center here. If Congress and President Trump succeed in dismantling the Affordable Care Act, he will have no insurance to pay for his medication or counseling, and he fears he will slide back to heroin. “If this gets taken from me, it’s right back to Square 1,” he said. “And that’s not a good place. I’m scary when I’m using. I don’t care who I hurt.” As the debate over the fate of the health law intensifies, proponents have focused on the lifesaving care it has brought to people with cancer, diabetes and other physical illnesses. But the law has also had a profound, though perhaps less heralded, effect on mental health and addiction treatment, vastly expanding access to those services by designating them as “essential benefits” that must be covered through the A.C.A. marketplaces and expanded Medicaid. The Center on Budget and Policy Priorities, a left-leaning research group, calculates that 2.8 million people with substance use disorders, including 220,000 with opioid disorders, have coverage under the A.C.A. As the opioid epidemic continues to devastate communities nationwide, public health officials say the law has begun to make a critical difference in their ability to treat and rehabilitate people. © 2017 The New York Times Company
Keyword: Drug Abuse
Link ID: 23215 - Posted: 02.11.2017
Sarah Boseley Health editor Low back and neck pain is an increasingly widespread and expensive condition worldwide, costing the US alone $88bn a year – the third highest bill for any health condition – despite evidence most treatments do not work. Millions of people worldwide suffer from low back and neck pain, most of it unexplained, although some professionals think it may be worsened by sitting at desks all day, carrying bags and general bad posture. Episodes of acute pain are very common, but experts say that medical investigations only make things worse and the best cure is often to take painkillers, exercise gently and wait for the pain to pass. The rising bill for treatment in the US has been uncovered in a new study by the Institute of Health Metrics and Evaluation (IHME) at the University of Washington, which looked at public and private spending on all diseases in 2013. Diabetes was in first place on $101.4bn and heart disease was second with $88.1bn. But neck and lower back pain treatment costs were close behind, at $87.6bn. The team split cancer into 29 separate conditions, which meant that none of them made the top 20, although combined the costs of treatment came to $115bn. The most remarkable thing, said Joseph Dieleman, lead author of the paper published in the Journal of the American Medical Association, was the increase in treatment costs for lower back and neck pain, running at 6.5% a year against 3.5% overall. “In absolute terms, there was an increase from $30bn in 1996 to $88bn in 2013,” he told the Guardian. © 2017 Guardian News and Media Limited
Keyword: Pain & Touch
Link ID: 23214 - Posted: 02.11.2017
After A Stroke At 33, A Writer Relies On Journals To Piece Together Her Own Story On New Year's Eve, 2006, Christine Hyung-Oak Lee developed a splitting headache. She was 33, and her world turned upside down — as in, she literally saw the world upside down. Suddenly, she could hold things in her mind for only 15 minutes at a time. She was a writer who now couldn't recall words or craft sentences. She remembers looking at the phone and thinking to herself: What is the phone number for 911? Days later, she learned she'd had a stroke. "I had a 15-minute short-term memory, like Dory the fish in Finding Nemo," Lee wrote in a Buzzfeed essay chronicling her experience. "My doctors instructed me to log happenings with timestamps in my Moleskine journal. That, they said, would be my working short-term memory. My memento to my mori." Lee used those journals to reconstruct her experience in a new memoir called Tell Me Everything You Don't Remember. She talks with NPR's Scott Simon about the silver linings of memory loss and the unexpected grief that came with her recovery. Interview Highlights On what it's like to have a 15-minute memory You don't even fathom the magnitude of your loss — or at least I didn't. I couldn't plan for the future. I couldn't think of the past. I had no regrets. So it's literally living in the moment. I was experiencing something that people go to yoga and Zen retreats to achieve. So it was quite pleasant. It was not pleasant for the people around me. But in that period of my recovery, where I couldn't remember everything, I think I was incredibly at peace and happy. On having an "invisible" disability It was frustrating. On the one hand, you want people to know: Hey, slow down for me. Hey, I'm going through a crisis. On the other hand, I was also privileged to be disabled in a way that wasn't visible. So people also didn't treat me any differently. So it was very isolating. ... When I told people that I was sick and I needed them to slow down, along with that came this need to explain my position and I ... felt a lot of resentment for having to do with that. © 2017 npr
By STEPH YIN If you’re reading this at home, pause and put on a song you can’t resist dancing to. Go on, bop your head to the beat. Let yourself wiggle a bit. Throw in some arms and legs. If you’re reading this at work, maybe imagine these things at your desk. As you’re dancing, pay attention to where and how you’re moving. How much are you swaying your hips? Are your legs moving together or independently of each other? How vigorously are you moving your torso? You should note those movements, because very specific patterns may make some people appear to be better dancers than others. That’s the conclusion of a study published on Thursday in Scientific Reports, in which researchers asked 200 people to rate 39 female dancers. A few features stood out as contributing to higher-quality dance: big hip swings, and the right and left limbs moving independently of one another (which the researchers describe as asymmetric arm and thigh movements). The researchers speculate that those moves serve two purposes for heterosexual women. “One is, they’re showing off their reproductive quality, perhaps their hormonal status, to males,” said Nick Neave, an associate professor of psychology at Northumbria University in England and an author of the paper. “Another is, they’re showing off how good they are to female rivals.” In 2011, the same researchers reported that women preferred certain dance moves by men, especially exaggerated movements in the upper body. In other studies, Dr. Neave and his colleagues have found links between male dance attractiveness and risk-taking, as well as handgrip strength, a marker for overall body strength. “We know that dance moves are signaling strength and vigor in males,” Dr. Neave said. “Now we’re beginning to do the same research with females.” In the study, his team asked 39 female university students in Britain to dance alone to a drum beat. The researchers used a motion-capture system to track the women’s moves. They animated each dancer as an avatar to try to make sure that only the dance movements — and no other physical features — would affect ratings. Then they recruited 57 men and 143 women to watch 15-second clips of the avatars and rate them each on a numeric scale. © 2017 The New York Times Company
Ian Sample Science editor Dozens of British children who developed narcolepsy as a result of a swine flu vaccine could be compensated after the high court rejected a government appeal to withhold payments. Six million people in Britain, and more across Europe, were given the Pandemrix vaccine made by GlaxoSmithKline during the 2009-10 swine flu pandemic, but the jab was withdrawn after doctors noticed a sharp rise in narcolepsy among those who received it. The sleep disorder is permanent and can cause people to fall asleep dozens of times a day. Some narcoleptics have night terrors and a muscular condition called cataplexy that can lead them to collapse on the spot. In 2015, a 12-year-old boy, known as John for the proceedings, was awarded £120,000 by a court that ruled he had been left severely disabled by narcolepsy caused by the vaccine. He was seven when he had the jab and developed symptoms within months. Because of his tiredness, John became disruptive at school and found it almost impossible to make friends. He takes several naps a day, cannot shower or take a bus on his own, and may never be allowed to drive a car. Despite paying out, the Department for Work and Pensions argued John’s disability was not serious enough to warrant compensation and said the court was wrong to take into account how the illness would affect him in the future. But the high court on Thursday rejected the government’s appeal that only the boy’s disability at the time should have been considered. The ruling paves the way for more than 60 other people to claim compensation. © 2017 Guardian News and Media Limited
Katherine Bourzac Kristopher Boesen, who broke his neck in a car accident, regained the ability to move his arms and hands after his spinal cord was injected with stem cells. Two years after having a stroke at 31, Sonia Olea Coontz remained partially paralysed on her right side. She could barely move her arm, had slurred speech and needed a wheelchair to get around. In 2013, Coontz enrolled in a small clinical trial. The day after a doctor injected stem cells around the site of her stroke, she was able to lift her arm up over her head and speak clearly. Now she no longer uses a wheelchair and, at 36, is pregnant with her first child. Coontz is one of stem-cell therapy's “miracle patients”, says Gary Steinberg, chair of neurosurgery at Stanford School of Medicine in California, and Coontz's doctor. Conventional wisdom said that her response was impossible: the neural circuits damaged by the stroke were dead. Most neuroscientists believed that the window for functional recovery extends to only six months after the injury. Stem-cell therapies have shown great promise in the repair of brain and spinal injuries in animals. But animal models often behave differently from humans — nervous-system injuries in rats, for example, heal more readily than they do in people. Clinical trial results have been mixed. Interesting signals from small trials have faded away in larger ones. There are plenty of unknowns: which stem cells are the right ones to use, what the cells are doing when they work and how soon after an injury they can be used. © 2016 Macmillan Publishers Limited,